Previous close | 0.8833 |
Open | 0.8800 |
Bid | 0.8784 x 100 |
Ask | 0.8861 x 200 |
Day's range | 0.8655 - 0.8890 |
52-week range | 0.6500 - 1.4900 |
Volume | |
Avg. volume | 1,673,035 |
Market cap | 352.63M |
Beta (5Y monthly) | 2.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Amarin (AMRN) secures a new patent for Vazkepa in Europe, which extends its exclusivity for eight more years. It achieves success in defending another patent on the drug against third parties.
Amarin ( NASDAQ:AMRN ) Full Year 2023 Results Key Financial Results Revenue: US$306.9m (down 17% from FY 2022). Net...
It's been a sad week for Amarin Corporation plc ( NASDAQ:AMRN ), who've watched their investment drop 11% to US$1.06 in...